Related Experiment Video
Updated: Feb 23, 2026

Murine Model of Thoracic Aortic Dissection Induced by Oral β-Aminopropionitrile and Subcutaneous Angiotensin II Infusion
Published on: May 16, 2025
Bisoprolol-induced thrombocytopenia: A case report
F Mousinho1, T Mendes1, P Sousa E Santos1
1Hematology Department, Hospital São Francisco Xavier, Centro Hospitalar de Lisboa Ocidental, Lisboa, Portugal.
Drug-induced thrombocytopenia is a common issue. This case highlights bisoprolol as a potential cause, resolving with discontinuation and steroids, and reviews immune mechanisms.
Area of Science:
- Pharmacology
- Hematology
- Immunology
Background:
- Thrombocytopenia, or low platelet count, is a frequent clinical challenge unrelated to primary bone marrow disorders.
- Drug-induced thrombocytopenia is a significant consideration, particularly in hospitalized individuals.
- Medications can induce thrombocytopenia through direct toxicity or immune-mediated pathways.
Observation:
- A case study of a patient presenting with thrombocytopenia potentially linked to bisoprolol use is detailed.
Findings:
- Bisoprolol was identified as the likely cause of the patient's thrombocytopenia.
- The condition resolved effectively upon discontinuation of bisoprolol and initiation of steroid therapy.
Implications:
- This case underscores the importance of considering drug-induced immune thrombocytopenia in differential diagnoses.
- Understanding the immune mechanisms of drug-induced thrombocytopenia is crucial for effective patient management.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
